[Amiodarone-induced pneumonitis associated with marked eosinophilia in BALF].
Sato
Suguru
S
Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, Fukushima.
Watanabe
Kana
K
Ishida
Takashi
T
Yoshikawa
Motoko
M
Kanazawa
Kenya
K
Saito
Junpei
J
Ohtsuka
Yoshinori
Y
Suzuki
Hitoshi
H
Maruyama
Yukio
Y
Munakata
Mitsuru
M
D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology*; D004804:Eosinophils; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D011657:Pulmonary Eosinophilia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D011239:Prednisolone; D000638:Amiodarone